Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jun 14.
Published in final edited form as: Synlett. 2017 Sep 1;28(20):2906–2912. doi: 10.1055/s-0036-1590899

Facile Synthesis of 3-Amido-Dienynes via a Tandem α-Propargylation–Isomerization of Chiral Allenamides and their Applications in Diels-Alder Cycloadditions

Zhi-Xiong Ma 1,*, Li-Chao Fang 1, Richard P Hsung 1,*
PMCID: PMC6000824  NIHMSID: NIHMS920914  PMID: 29910538

Abstract

A series of de novo 3-amido-dienynes was synthesized via tandem α-propargylation–isomerization of chiral allenamides with moderate E/Z ratio. Reactivities of E-and Z-isomers were examined.

Keywords: allenamide, tandem, 3-amido-dienyne, propargylation, Diels-Alder reaction

Graphical abstract

graphic file with name nihms920914u1.jpg


Recently, we developed a highly E-selective allenamide 1,3-H shift reaction under thermal or acid-promoted condition, which afforded an efficient route to access valuable 2-amidodiene building blocks.1,2 Furthermore, chiral 3-amidotrienes such as 2 could be prepared by the reactions starting from α-allyl-allenamides 1 (path a, scheme 1), which could be facilely converted to cyclic 2-amidodienes 4 and further applied in various different transformations.1, 3

Scheme 1.

Scheme 1

3-amidotrienes formation via 1,3-H-shift and the design to 3-amidodenynes

While much efforts have been dedicated to 3-amidotrienes, we were also interested in the reactivity and potential application of its structural sibling 3-amidodienynes, which could potentially be obtained following a similar α-propargylation–1,3-H shift sequence of allenamides (path b, scheme 1). Comparing to 3-amidotrienes, precedents of 3-amino-or 3-amido-dienynes are relative rare.4–7 An elegant example of 3-amidodienynes was reported recently by Huang and coworker in which they developed an interesting route to 1-silyloxy-3-aminodienynes, and subsequently, applied these electronically enriched 3-aminodienyens in different ring-formation reactions.7 Herein, we wish to disclose our recent studies on the preparation of 3-amidodienyens and exploration of the reactivity of both E-and Z-isomers.

Given that 3-amidodienynes could be obtained via a 1,3-H-shift of the corresponding α-propargyl allenamides, we commenced our study through examining the propargylation of allenamides using 6a bearing an i-Pr substituent on the oxazolidinone ring. To our surprise, under the standard alkylation conditions (n-BuLi, HMPA, propargyl bromide), in addition to the expected α-propargyl allenamide product 4a, two new products were isolated from the reaction mixture. These two additional products turned to be the E/Z isomers of the desired 3-amidodienynes 5a (entry 1, table 1). The direct formation of 3-amidodienynes could be promoted by base-promoted in situ 1,3-H-shift of α-propargyl allenamide in the presence of excess n-BuLi used for allenamide deprotonation, or even the α-deprotonated allenamide, although the exact mechanism remains unclear.8 Efforts to improve the conversion toward 3-amidodienyne formation, such as increasing the amount of n-BuLi and prolonged reaction time, proved to be fruitless.

Table 1.

Propargylation of allenamidesa

graphic file with name nihms920914u2.jpg
Entry allenamide Propargyl bromide 4/ E-5/ Z-5 (Yields %)b
1 6a (R = i-Pr) 7a (R1 = Me) 4a/ E-5a/ Z-5a (34/15/26)
2c 6a (R = i-Pr) 7b (R1 = TMS) 4b/ E-5b/ Z-5b (0/15/26)
3 6b (R = Bn) 7a (R1 = Me) 4c/ E-5c/ Z-5c (38/14/23)
4 6c (R = CHPh2) 7a (R1 = Me) 4d/ E-5d/ Z-5d (41/12/19)
5 6c (R = CHPh2) 7c (R1 = Ph) 4e/ E-5e/ Z-5e (0/13/22)
a

Reaction Conditions: n-BuLi (1.5 equiv.) was added to allenamide 6 (1.0 equiv) in HMPA (1.5 equiv) and THF (0.1 M) at −78°C. Propargyl bromide 7 (1.5 equiv) was added 45 min later and the reaction was stirred at −78 °C for 1 h and then warmed to rt overnight.

b

Isolated yields in the bracket.

c

All yields were overall yields of E/Z-5b (R1 = H) after removal of TMS of the directly formed 3-amidodienynes products with TBAF since TMS protected 3-amidodienyne isomers were inseparable. TMS = trimethylsilyl.

Although this tandem propargylation–1,3-H-shift sequence afforded 3-amidodienynes in moderate E/Z ratios, we were satisfied with the efficiency that both isomers could be obtained in one-pot to set the stage for evaluation of their respective reactivities and potential applications. By employing the standard conditions, we examined tandem propargylation–1,3-H-shift reactions using combinations of different chiral allenamides and substituted propargyl bromides (entries 2–5, table 1). Generally, all these reactions proceeded smoothly in the standard conditions with different oxazolidinone auxiliaries. Interestingly, when either TMS (entry 2, table 1) or Ph (entry 5, table 1) substituted propargyl bromides was used, only 3-amidodienyne products were found in moderate yield with no α-propargyl allenamides isolated. This could a result of enhanced activity of propargylic protons in the initial α-propargylated allenamide toward base-promoted 1,3-H-shift.

With these 3-amidodienynes in hand, their potential synthetic applications were investigated. We envisioned that these highly electron-rich Z-3-amidodienynes could serve as suitable diene components in a Diels-Alder cycloaddition reaction with the alkyne motif preserved as a useful handle for further transformations. Towards this goal, Diels-Alder reaction of Z-5a with methyl vinyl ketone (MVK) was explored. Considering the potential labile property of the substrate in the presence of Lewis acids, conventional thermal condition was selected for the Diels-Alder reaction and Z-5a was found to react smoothly with MVK at 130 °C in the presence of BHT (2,6-Di-tert-butyl-4-methylphenol) to afford the desired product 9a in 56% yield with a diastereomeric ration of 8:1 (entry 1, table 2). Inspired by these results, the Diels-Alder reactions were further examined with other Z-3-amidodienynes (entries 2–6, table 2) under the standard thermal conditions. It was readily noticeable that the auxiliary employed played a key role in the reaction selectivity (entries 1,3, and 4). While Z-5c bearing a Bn substituted Evans auxiliary gave inferior selectivity comparing to Z-5a with an i-Pr substituent, the reaction with Z-5d incorporated with a Sibi auxiliary provided the cycloaddition product as a single isomer.9 Similar selectivity results were also observed in our previous studies.3c

Table 2.

Diels-Alder reaction of 3-amidodienynesa

graphic file with name nihms920914f4.jpg
a

Reaction Conditions: A solution of Z-3-amidodienyne (1 qeuiv), MVK (10 equiv) and BHT (2.0 equiv) in toluene (3 mL) in a sealed tube was heated at 130 °C overnight.

b

Isolated yields and ratios of endo-II/endo-I in the bracket.

c

3 equiv. of dienophile was used.

d

The reaction was sluggish.

While it would appear that these cycloadditions were compatible with variations on the alkyne motif (entries 2 and 5), the reaction with a terminal alkyne substrate gave relatively lower yield (entry 2). Other dienophiles such as 8b and 8c were also examined (entries 6 and 7). Dienophile 8b with p-bromophenyl substitution was tolerant and it offered the desired product 9f in good yield and selectivity under standard conditions. On the other hand, when 8c with terminal phenyl substituent on the double bond (entry 7), the reaction became very sluggish even at higher temperature. The prolonged reaction time resulted in a messy reaction mixture with decomposition of the starting material, although the desired product was detected from the reaction mixture by mass spectrometry. This outcome suggests that the cycloaddition was quite sensitive to the β-substitutions of these enones. We also attempted the reaction with 2-cyclohexen-1-one (results not shown in the table), but no desired product was found with only slow decomposition of the starting material.

NOE experiment using cycloadduct 9f confirmed its 1,3-cis relative stereochemistry, thereby suggesting an endo-selectivity for these cycloadditions. Furthermore, based on the mechanistic model from our previous studies using related amino-dienes, these Diels-Alder products would be assigned as endo-II cycloaddition products as shown in scheme 2.3c,d.

Scheme 2.

Scheme 2

Structure assignment of the Diels-Alder reaction products

Having established a reliable Diels-Alder reaction of Z-3-amidodienynes established, we then focused on the reaction of E-3-amidodienynes. Given the similarity to 3-amidotrienes, these E-3-amidodienynes were postulated to be intrinsic candidates for electrocyclizations or similar transformations.10 Thus, we attempted to directly cyclize E-5a various conditions (Ti(OPr)4, (JohnPhos)AuCl/AgSbF6, PtCl4 conventional heating, photo-activation conditions and so on), but none of these conditions led to desired products with decompositions being the case in most attempts (reaction a, scheme 3). When the direct cyclization failed to offer the desired product, a sequence of Pauson-Khand reaction-6π-electrocyclization was envisioned and explored (reaction b, scheme 3).11 Albeit in low yield (in 28% yield un-optimized), E-5a did react with norbornene to afford the desired Pauson-Khand product 11. However, analysis selectivity was poor (roughly 1:1), which could be due to the long distance between the chiral auxiliary and the actual rsite of bond of formation. Unfortunately, initial attempts at 6π-electrocyclizations of 11 to give the octahydro-fluroenone derivative 12 proved to be challenging. Efforts are currently underway to achieve such synthetic design.

Scheme 3.

Scheme 3

Reactions of E-3-amidodienynes

We have described here a tandem propargylation–1,3-H-shift sequence to access both E-and Z-isomer of chiral 3-amidodienynes. A series of 3-amidodienynes were synthesized with this method. An application of Z-3-amidodienynes in Diels-Alder cycloadditions gave endo-II products in good yields and excellent selectivity. Reactivity of the corresponding E-3-amidodienynes toward electrocyclization was also examined but was unsuccessful. Further efforts in developing synthetic applications of these de novo chiral 3-amindo-dienynes will be reported in due courses.

Supplementary Material

Supp Info

Acknowledgments

The authors thank NIH (GM-66055) for generous funding. RPH thanks Laura and Edward Kremers Family Foundation for a generous endowed chair in natural products chemistry.

Footnotes

Supporting Information

YES (this text will be updated with links prior to publication)

Primary Data

NO (this text will be deleted prior to publication)

References and Notes

  • 1.(a) Hayashi R, Hsung RP, Feltenberger JB, Lohse AG. Org Lett. 2009;11:2125. doi: 10.1021/ol900647s. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hayashi R, Feltenberger JB, Hsung RP. Org Lett. 2010;12:1152. doi: 10.1021/ol902821w. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Hayashi R, Walton MC, Hsung RP, Schwab J, Yu X. Org Lett. 2010;12:5768. doi: 10.1021/ol102693e. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Hayashi R, Feltenberger JB, Lohse AG, Walton MC, Hsung RP. Beil J Org Chem. 2011;7:410. doi: 10.3762/bjoc.7.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.(a) Hsung RP, Wei LL, Xiong H. Acc Chem Res. 2003;36:773. doi: 10.1021/ar030029i. [DOI] [PubMed] [Google Scholar]; (b) Lu T, Lu Z, Ma ZX, Zhang Y, Hsung RP. Chem Rev. 2013;113:4862. doi: 10.1021/cr400015d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.(a) Feltenberger JB, Hsung RP. Org Lett. 2011;13:3114. doi: 10.1021/ol2010227. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hayashi R, Ma ZX, Hsung RP. Org Lett. 2012;14:252. doi: 10.1021/ol203030a. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Fang LC, Hsung RP, Ma ZX, Presser WR. Org Lett. 2013;15:4842. doi: 10.1021/ol402254p. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Fang LC, Hsung RP. Org Lett. 2014;16:1826. doi: 10.1021/ol500390a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.In terms of 3-amidotrienes/dienynes, those with alkenes as part of an aromatic system were not considered here.
  • 5.(a) Camphell CD, Greenaway RL, Holton OT, Walker PB, Chapman HA, Russell CA, Carr G, Thomson AL, Anderson EA. Chem Eur J. 2015;21:12627. doi: 10.1002/chem.201501710. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Huntley RJ, Funk RL. Tetrahedron Lett. 2011;52:6671. doi: 10.1016/j.tetlet.2011.09.138. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Greshock TJ, Funk RL. J Am Chem Soc. 2006;128:4946. doi: 10.1021/ja060282o. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Barluenga J, Aznar F, Cabal M, Valdés C. J Chem Soc Perkin Trans I. 1990;633 [Google Scholar]
  • 6.Li X, Peng S, Huang Y. Nat Commun. 2015;6:6913. doi: 10.1038/ncomms7913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.(a) Aguilar E, Sanz R, Fernández-Rodríguez MA, García-García P. Chem Rev. 2016;116:8256. doi: 10.1021/acs.chemrev.6b00181. [DOI] [PubMed] [Google Scholar]; (b) Hitt DM, O’Connor JM. Chem Rev. 2011;111:7904. doi: 10.1021/cr2001542. [DOI] [PubMed] [Google Scholar]; (c) Zimmermann G. Eur J Org Chem. 2001;457 [Google Scholar]
  • 8.Sometimes a trace amount of the starting allenamide was detected after the reaction, which implies deprotonation by the α-deprotonated allenamide.
  • 9.Sibi MP, Porter NA. Acc Chem Res. 1999;32:163. [Google Scholar]
  • 10.(a) Marvell EN. Thermal Electrocyclic Reactions. Academic Press; New York: 1980. [Google Scholar]; (b) Okamura WH, de Lera AR. In: Comprehensive Organic Synthesis. Trost BM, Fleming I, Paquette LA, editors. Vol. 5. Pergamon Press; New York: 1991. pp. 699–750. [Google Scholar]
  • 11.Khand IU, Knox GR, Pauson PL, Watts WE, Foreman MI. J Chem Soc Perkin Trans I. 1973:977. [Google Scholar]
  • 12.General procedures for the propargylation/1,3-H-shift sequence of allenamides: To a solution of allenamide 6a (1.0 equiv) and HMPA (1.5 equiv) in THF (0.1 M) was added dropwise n-BuLi (2.5 M in Hexanes, 1.5 equiv) at −78 °C. After stirring for 45 min, propargyl bromide 7a (1.5 equiv) was added dropwise. The resulting solution was stirred at −78 °C for 1 h and then at rt for overnight. The reaction mixture was quenched with sat. aq. NH4Cl solution, extracted with EtOAc(3 times). The combined organic phases were washed with sat. aq. NaCl solution, dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford a crude product which was purified via silica gel flash column chromatography [gradient eluent: EtOAc in hexane] to afford the desired products 4a and E/Z-5a.
  • 13.Characterization of α-propargyl allenamide product 4 and 3-amidodienynes 54a (77 mg, 34%), E-5a (34 mg, 15%) and Z-5a (59 mg, 26%) were obtained from allenamide 6a (172 mg) according to the general procedure.4a: pale yellow oil; Rf = 0.45 (hexane:EtOAc = 2:1); [α]D25 = 27.2 (c = 2.40, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.89 (d, J = 7.0 Hz, 3H), 0.93 (d, J = 7.0 Hz, 3H), 1.78 (t, J = 3.0 Hz, 3H), 2.16 (dqq, J = 3.5, 7.0, 7.0 Hz, 1H), 3.35 (ABMNX3, JAM = JBM = JMX = 2.5 Hz, JMN = 18 Hz, 1H), 3.45 (ABMNX3, JNX = 2.5 Hz, JAN = JBN = 3.5 Hz, JMN = 18 Hz, 1H), 3.91 (ddd, J = 3.5, 5.5, 9.0 Hz, 1H), 4.12 (dd, J = 6.0, 8.5 Hz, 1H), 4.28 (dd, J = 9.0, 9.0 Hz, 1H), 5.19 (ABMN, JAM = 2.5 Hz, JAN = 3.5 Hz, JAB = 10.5 Hz, 1H), 5.31 (ABMN, JBM = 2.5 Hz, JBN = 3.5 Hz, JAB = 10.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 3.7, 14.6, 17.9, 21.7, 28.2, 60.9, 63.3, 74.7, 78.2, 84.5, 105.5, 156.4, 204.4; IR (thin film) cm−1 3391brs, 2966w, 1748s, 1638w, 1452w, 1405m; HRMS (QTOF MS ESI) m/e calcd for C13H18NO2 [M + H]+ 220.1332, found 220.1328.E-5a: pale yellow oil; Rf = 0.42 (hexane:EtOAc = 2:1); [α]D25 = 174.3 (c = 0.88, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.86 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H), 1.91 (dqq, J = 4.0, 6.8, 6.8 Hz, 1H), 2.03 (d, J = 2.4 Hz, 3H), 4.01 (ddd, J = 4.0, 5.6, 8.8 Hz, 1H), 4.15 (dd, J = 7.0, 9.2 Hz, 1H), 4.35 (dd, J = 8.8, 8.8 Hz, 1H), 5.29–5.41 (m, 2H), 5.67 (s, 1H), 6.77 (dd, J = 11.2, 17.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 4.96, 14.8, 18.0, 29.0, 61.2, 63.5, 75.3, 96.9, 111.8, 117.8, 129.7, 141.9, 156.8; IR (thin film) cm−1 3483brs, 2964w, 1747s, 1623w, 1576w, 1485w, 1402m; HRMS (QTOF MS ESI) m/e calcd for C13H18NO2 [M + H]+ 220.1332, found 220.1329.Z-5a: pale yellow oil; Rf = 0.40 (hexane:EtOAc = 2:1); [α]D25 = −24.3 (c = 0.85, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.91 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 7.0 Hz, 3H), 1.90–1.98 (m, 1H), 2.03 (d, J = 2.5 Hz, 3H), 4.19–4.21 (m, 1H), 4.35–4.41 (m, 2H), 5.25 (d, J = 10.5 Hz, 1H), 5.41 (d, J = 17.5 Hz, 1H), 5.69 (q, J = 2.5 Hz, 1H), 6.29 (dd, J = 10.5, 17.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 5.1, 16.0, 18.7, 29.7, 61.2, 64.7, 75.9, 97.8, 110.7, 117.2, 133.2, 142.6, 156.2; IR (thin film) cm−1 3422brs, 2966w, 1749s, 1485w, 1406m; HRMS (QTOF MS ESI) m/e calcd for C13H18NO2 [M + H]+ 220.1332, found 220.1330.E-5b (165 mg, 15%) and Z-5b (285 mg, 26%) were obtained from allenamide 6a (912 mg) according to the general procedure.E-5b: pale yellow oil; Rf = 0.35 (hexane:EtOAc = 2:1); [α]D25 = 88.0 (c = 1.21, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.88 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H), 1.94 (dqq, J = 3.5, 7.0, 7.0 Hz, 1H), 3.43 (d, J = 2.5 Hz, 3H), 4.06 (ddd, J = 3.5, 5.0, 8.5 Hz, 1H), 4.18 (dd, J = 5.5, 9.0 Hz, 1H), 4.37 (dd, J = 8.5, 9.0 Hz, 1H), 5.46 (d, J = 11.0 Hz, 1H), 5.51 (d, J = 17.5 Hz, 1H), 5.72 (s, 1H), 6.78 (dd, J = 11.0, 17.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.7, 18.0, 29.0, 61.2, 63.5, 79.1, 87.3, 108.7, 119.7, 129.5, 144.7, 156.5; IR (thin film) cm−1 3303w, 3018w, 1748s, 1573w, 1485w, 1402m; HRMS (QTOF MS ESI) m/e calcd for C12H16NO2 [M + H]+ 206.1176, found 206.1174.Z-5b: pale yellow oil; Rf = 0.31 (hexane:EtOAc = 2:1); [α]D25 = −5.6 (c = 1.62, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.91 (d, J = 7.0 Hz, 3H), 0.95 (d, J = 6.5 Hz, 3H), 1.95 (dqq, J = 4.0, 7.0, 7.0 Hz, 1H), 3.46 (d, J = 2.5 Hz, 1H), 4.19 (dd, J = 6.0, 8.5 Hz, 1H), 4.40 (dd, J = 8.5, 9.0 Hz, 1H), 4.47 (ddd, J = 4.0, 6.0, 8.5 Hz, 1H), 5.34 (d, J = 10.5 Hz, 1H), 5.52 (d, J = 17.0 Hz, 1H), 5.69 (d, J = 2.5 Hz, 1H), 6.31 (dd, J = 10.5, 17.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 16.0, 18.5, 29.6, 61.0, 64.7, 79.4, 88.2, 107.7, 119.0, 132.9, 145.3, 155.9; IR (thin film) cm−1 3301w, 3016w, 2970w, 1749s, 1585w, 1485w, 1406m; HRMS (QTOF MS ESI) m/e calcd for C12H16NO2 [M + H]+ 206.1176, found 206.1174.4c (244 mg, 38%), E-5c (89 mg, 14%) and Z-5c (151 mg, 23%) were obtained from allenamide 6b (518 mg) according to the general procedure.4c: pale yellow oil; Rf = 0.60 (hexane:EtOAc = 2:1); [α]D25 = 24.4 (c = 0.95, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.81 (t, J = 2.5 Hz, 3H), 2.71 (dd, J = 9.0, 14.0 Hz, 1H), 3.27 (dd, J = 3.5, 14.0 Hz, 1H), 3.42 (ABMNX3, JAM = JBM = JMX = 2.5 Hz, JMN = 18 Hz, 1H), 3.48 (ABMNX3, JNX = 2.5 Hz, JAN = JBN = 3.0 Hz, JMN = 18 Hz, 1H), 4.81 (dd, J = 5.5, 8.0 Hz, 1H), 4.14–4.20 (m, 1H), 4.23 (dd, J = 8.0, 8.0 Hz, 1H), 5.29 (ABMN, JAM = 1.5 Hz, JAN = 3.0 Hz, JAB = 10.5 Hz, 1H), 5.40 (ABMN, JBM = 2.0 Hz, JBN = 3.0 Hz, JAB = 10.5 Hz, 1H), 7.16–7.18 (m, 2H), 7.25–7.28 (m, 1H), 7.31–7.34 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 3.6, 21.8, 38.6, 58.2, 67.1, 74.6, 78.3, 85.0, 105.8, 127.3, 129.1, 129.3, 135.9, 155.8, 204.3; IR (thin film) cm−1 3369brs, 3027w, 2920w, 1749s, 1604w, 1497w, 1479w, 1453m, 1402m; HRMS (QTOF MS ESI) m/e calcd for C17H18NO2 [M + H]+ 268.1332, found 268.1328.E-5c: pale yellow solid, mp 46–47 °C; Rf = 0.55 (hexane:EtOAc = 2:1); [α]D25 = 70.0 (c = 0.91, CHCl3); 1H NMR (500 MHz, CDCl3) δ 2.07 (d, J = 2.5 Hz, 3H); 2.59 (dd, J = 10.0, 13.5 Hz, 1H), 3.07 (dd, J = 3.5, 13.5 Hz, 1H), 4.11–4.15 (m, 1H), 4.22–4.30 (m, 2H), 5.41 (d, J = 10.5 Hz, 1H), 5.43 (d, J = 17.5 Hz, 1H), 5.74 (m, 1H), 6.88 (dd, J = 11. 0, 17.5 Hz, 1H), 7.10–7.12 (m, 2H), 7.24–7.27 (m, 1H), 7.30–7.32 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 5.0, 39.0, 58.5, 67.3, 75.2, 97.2, 112.5, 117.9, 127.4, 129.1, 129.2, 135.5, 141.7, 156.3; IR (thin film) cm−1 3405brs, 3016w, 2918w, 1753s, 1624w, 1497w, 1479w, 1454w, 1403m; HRMS (QTOF MS ESI) m/e calcd for C17H18NO2 [M + H]+ 268.1332, found 268.1327.Z-5c: pale yellow oil; Rf = 0.52 (hexane:EtOAc = 2:1); [α]D25 = −57.6 (c = 1.09, CHCl3); 1H NMR (500 MHz, CDCl3) δ 2.06 (d, J = 2.5 Hz, 3H), 2.67 (dd, J = 10.5, 13.5 Hz, 1H), 3.11 (dd, J = 4.0, 13.5 Hz, 1H), 4.18 (dd, J = 7.0, 9.0 Hz, 1H), 4.32 (dd, J = 8.5, 8.5 Hz, 1H), 4.63 (dddd, J = 4.0, 8.0, 9.0, 11.0 Hz, 1H), 5.29 (d, J = 10.5 Hz, 1H), 5.44 (d, J = 17.0 Hz, 1H), 5.77 (q, J = 2.0 Hz, 1H), 6.37 (dd, J = 10.5, 17.0 Hz, 1H), 7.14–7.15 (m, 2H), 7.24–7.27 (m, 1H), 7.30–7.33 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 5.2, 39.2, 58.1, 68.3, 75.8, 98.0, 111. 8, 117.2, 127.3, 129.1, 129.2, 133.3, 135.9, 141.9, 155.8; IR (thin film) cm−1 3406brs, 3017w, 1752s, 1498w, 1405m; HRMS (QTOF MS ESI) m/e calcd for C17H18NO2 [M + H]+ 268.1332, found 268.1328.4d (142 mg, 41%), E-5d (40 mg, 12%) and Z-5d (66 mg, 19%) were obtained from allenamide 6c (291 mg) according to the general procedure.4d: pale yellow oil; Rf = 0.45 (hexane:EtOAc = 2:1); [α]D25 = −70.1 (c = 1.10, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.76 (t, J = 2.5 Hz, 3H), 3.05 (ABMNX3, JAM = JMX = 2.5 Hz, JBM = 3.5 Hz, JMN = 18.5 Hz, 1H), 3.28 (ABMNX3, JNX = JAN = JBN = 2.5 Hz, JMN = 18.5 Hz, 1H), 4.17 (dd, J = 5.0, 9.0 Hz, 1H), 4.40 (d, J = 9.0 Hz, 1H), 4.42 (d, J = 6.0 Hz, 1H), 4.77 (ddd, J = 5.0, 6.5, 11.5 Hz, 1H), 5.05 (ABMN, JAM = JAN = 3.0 Hz, JAB = 10.5 Hz, 1H), 5.31 (ABMN, JBN = 3.0 Hz, JBM = 3.5 Hz, JAB = 10.5 Hz, 1H), 7.19–7.20 (m, 4H), 7.23–7.26 (m, 2H), 7.29–7.34 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 3.7, 21.7, 53.5, 59.4, 65.8, 74.3, 78.5, 84.6, 105.5, 127.3, 127.6, 128.5, 128.9 (2 carbons), 129.0, 139.4, 140.7, 156.2, 205.2; IR (thin film) cm−1 3397brs, 3017w, 2920w, 1750s, 1495w, 1452w, 1405m; HRMS (QTOF MS ESI) m/e calcd for C23H22NO2 [M + H]+ 344.1645, found 344.1636.E-5d: yellow solid, mp 52–53 °C; Rf = 0.40 (hexane:EtOAc = 2:1); [α]D25 = 1.5 (c = 0.72, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.96 (d, J = 2.5 Hz, 3H), 4.14 (d, J = 8.0 Hz, 1H), 4.20 (dd, J = 5.0, 9.0 Hz, 1H), 4.39 (dd, J = 9.0, 9.0 Hz, 1H), 4.93 (ddd, J = 5.0, 8.5, 8.5 Hz, 1H), 5.28 (d, J = 10.0 Hz, 1H), 5.30 (d, J = 17.5 Hz, 1H), 5.33 (m, 1H), 6.48 (dd, J = 11.0, 17.5 Hz, 1H), 7.15–7.32 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 5.0, 55.6, 59.1, 66.3, 75.1, 96.7, 113.4, 116.9, 127.4, 127.7, 128.4 (2 carbons), 128.8, 129.3, 130.0, 139.8, 140.4, 141.6, 156.7; IR (thin film) cm−1 3398brs, 3018w, 1751s, 1495w, 1453w, 1403m; HRMS (QTOF MS ESI) m/e calcd for C23H22NO2 [M + H]+ 344.1645, found 344.1639.Z-5d: yellow solid, mp 54–55 °C; Rf = 0.38 (hexane:EtOAc = 2:1); [α]D25 = −82.0 (c = 0.76, CHCl3); 1H NMR (500 MHz, CDCl3) δ 2.12 (d, J = 2.5 Hz, 3H), 4.11 (dd, J = 7.0, 9.0 Hz, 1H), 4.15 (d, J = 10.0 Hz, 1H), 4.35 (dd, J = 9.0 Hz, 9.0 Hz, 1H), 5.05 (d, J = 11.0 Hz, 5.25–5.30 (m, 2H), 5.41 (ddd, J = 7.0, 8.5, 10.0 Hz, 1H), 5.82 (dd, J = 10.5, 17.0 Hz, 1H), 7.14–7.31 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 5.2, 56.7, 58.8, 67.5, 76.2, 97.6, 111.3, 116.6, 127.3, 127.6, 128.0, 128.3 (2 carbons), 129.3, 133.0, 140.5, 140.7, 143.1, 156.3; IR (thin film) cm−1 3375brs, 3018w, 1753s, 1641w, 1494w, 1403m; HRMS (QTOF MS ESI) m/e calcd for C23H22NO2 [M + H]+ 344.1645, found 344.1639.E-5e (37 mg, 13%) and Z-5e (63 mg, 22%) were obtained from allenamide 6c (206 mg) according to the general procedure.E-5e: yellow solid, mp 57–58 °C; Rf = 0.40 (hexane:EtOAc = 2:1); [α]D25 = 19.8 (c = 0.44, CHCl3); 1H NMR (500 MHz, CDCl3) δ 4.19 (d, J = 8.5 Hz, 1H), 4.22 (dd, J = 5.0, 9.0 Hz, 1H), 4.42 (dd, J = 9.0, 9.0 Hz, 1H), 4.99 (ddd, J = 5.0, 8.5, 8.5 Hz, 1H), 5.36 (d, J = 11.0 Hz, 1H), 5.41 (d, J = 17.5 Hz, 1H), 5.60 (s, 1H), 6.55 (dd, J = 11.0, 17.5 Hz, 1H), 7.17–7.20 (m, 3H), 7.23–7.28 (m, 6H), 7.31–7.34 (m, 4H), 7.37–7.39 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 55.7, 59.3, 66.4, 84.8, 99.4, 112.0, 118.0, 123.3, 127.5, 127.7, 128.4, 128.5 (2 carbons), 128.7, 128.9, 129.3, 130.1, 131.5, 139.7, 140.3, 142.3, 156.6; IR (thin film) cm−1 3424brs, 3017w, 2920w, 1753s, 1599w, 1490w, 1453m, 1402m; HRMS (QTOF MS ESI) m/e calcd for C28H24NO2 [M + H]+ 406.1802, found 406.1794.Z-5e: yellow solid, mp 65–66 °C; Rf = 0.36 (hexane:EtOAc = 2:1); [α]D25 = −100.4 (c = 0.53, CHCl3); 1H NMR (500 MHz, CDCl3) δ 4.15 (dd, J = 6.5, 9.0 Hz, 1H), 4.20 (d, J = 10.0 Hz, 1H), 4.40 (dd, J = 9.0, 9.0 Hz, 1H), 5.13 (d, J = 10.5 Hz, 1H), 5.37 (d, J = 17.0 Hz, 1H), 5.49–5.54 (m, 2H), 5.91 (dd, J = 10.5, 17.0 Hz, 1H), 7.16–7.21 (m, 4H), 7.24–7.29 (m, 6H0, 7.38–7.40 (m, 3H), 7.47–7.50 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 56.8, 59.1, 67.5, 85.9, 100.4, 110.3, 117.4, 123.1, 127.4, 127.6, 128.0, 128.3, 128.4, 128.8, 129.2, 129.4, 131.7, 133.0, 140.4, 140.6, 144.0, 156.2; IR (thin film) cm−1 3398brs, 3019w, 1753s, 1490w, 1403m; HRMS (QTOF MS ESI) m/e calcd for C28H24NO2 [M + H]+ 406.1802, found 406.1795.
  • 14.General procedures for the Diels-Alder reaction of Z-3-amidodienynes: In a sealed tube, to a solution of diene Z-5 (1.0 equiv) in toluene (3 mL) was added 8 (10.0 equiv) and BHT (2.0 equiv) at room temperature, and the reaction vessel was well sealed and heated to 130 °C overnight. After cooling to rt, the reaction mixture was concentrated under reduced pressure and the resulting crude residue was directly used for crude 1H NMR analysis to determine isomer ratio. Then, the mixture was purified via silica gel flash column chromatography [gradient eluent: EtOAc in hexane] to afford the desired Diels-Alder product 9.
  • 15.Characterization of the Diels-Alder products 9.9a was obtained (15 mg, 58%) on a 20.0 mg scale reaction as a pale yellow oil according to the general procedure; Rf = 0.20 (hexane:EtOAc = 2:1); [α]D25 = 182.7 (c = 0.33, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.89 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 1.62–1.68 (m, 1H), 1.73 (d, J = 2.5 Hz, 3H), 2.01–2.08 (m, 2H), 2.10–2.18 (m, 1H), 2.26 (s, 3H), 2.30–2.37 (m, 1H), 2.96 (ddd, J = 3.0, 10.0, 10.0 Hz, 1H), 3.57–3.60 (m, 1H), 4.06–4.13 (m, 2H), 4.29 (dd, J = 8.5, 8.5 Hz, 1H), 5.84 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 3.7, 14.9, 18.0, 23.3, 23.6, 29.1, 29.3 (2 carbons), 53.4, 59.1, 63.1, 78.3, 123.7, 130.8, 157.3, 209.6; IR (thin film) cm−1 3404brs, 2963w, 2922w, 1746s, 1712m, 1670w, 1485w, 1411m; HRMS (QTOF MS ESI) m/e calcd for C17H24NO3 [M + H]+ 290.1751, found 290.1750.9b was obtained (12 mg, 20%) on a 45.0 mg scale reaction as a pale yellow oil according to the general procedure; Rf = 0.40 (hexane:EtOAc = 1:1); [α]D25 = 110.6 (c = 1.60, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.88 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.5 Hz, 3H), 1.65–1.72 (m, 1H), 2.04–2.18 (m, 3H), 2.08 (d, J = 3.0 Hz, 1H), 2.26 (s, 3H), 2.31–2.38 (m, 1H), 3.00 (ddd, J = 3.5, 7.0, 10.0 Hz, 1H), 3.68–3.70 (m, 1H), 4.06–4.12 (m, 2H), 4.29 (dd, J = 8.5, 8.5 Hz, 1H), 5.85–5.87 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 1.2, 14.9, 18.0, 23.1, 23.4, 28.9, 29.0, 53.0, 59.0, 63.0, 70.8, 82.4, 124.1, 129.6, 157.1, 208.8; IR (thin film) cm−1 3302brs, 2963w, 1746s, 1712m, 1671w, 1485w, 1411m; HRMS (QTOF MS ESI) m/e calcd for C16H22NO3 [M + H]+ 276.1594, found 276.1594.9c was obtained (12 mg, 63%) on a 15.0 mg scale reaction as a pale yellow oil according to the general procedure; Rf = 0.40 (hexane:EtOAc = 1:1); [α]D25 = 40.0 (c = 0.77, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.64–1.71 (m, 1H), 1.75 (d, J = 2.0 Hz, 3H), 2.02–2.16 (m, 2H), 2.26 (s, 3H), 2.28–2.35 (m, 1H), 2.70 (dd, J = 4.0, 14.0 Hz, 1H), 2.94 (ddd, J = 3.5, 6.5, 9.0 Hz, 1H), 3.19 (dd, J = 4.5, 13.5 Hz, 1H), 3.61–3.63 (m, 1H), 4.09 (dd, J = 5.0, 8.5 Hz, 1H), 4.28 (dd, J = 8.5, 8.5 Hz, 1H), 4.33–4.39 (m, 1H), 5.85 (ddd, J = 2.0, 4.0, 4.0 Hz, 1H), 7.16–7.21 (m, 2H), 7.24–2.27 (m, 1H), 7.31–7.34 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 3.8, 22.8, 23.3, 28.8, 29.3, 39.4, 53.3, 56.5, 67.0, 77.3, 78.5, 123.8, 127.3, 129.0, 129.5, 130.7, 136.2, 156.6, 209.2; IR (thin film) cm−1 3417brs, 2921w, 2850w, 1750s, 1711m, 1671w, 1497w, 1480w, 1454w, 1407m; HRMS (QTOF MS ESI) m/e calcd for C21H24NO3 [M + H]+ 338.1751, found 338.1749.9d was obtained (26 mg, 72%) on a 30.0 mg scale reaction as a yellow oil according to the general procedure; Rf = 0.30 (hexane:EtOAc = 1:1); [α]D25 = 14.8 (c = 0.93, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.91 (dddd, J = 5.5, 11.0, 11.0, 13.0 Hz, 1H), 1.70–1.74 (m, 1H), 1.75 (d, J = 2.5 Hz, 3H), 1.78–1.85 (m, 1H), 2.062.15 (m, 1H), 2.19 (s, 3H), 2.72 (ddd, J = 3.0, 9.0, 12.0 Hz, 1H), 3.20–3.22 (m, 1H), 4.07 (dd, J = 5.0, 9.0 Hz, 1H), 4.25 (d, J = 9.0 Hz, 1H), 4.39 (dd, J = 9.0 Hz, 1H), 4.88 (ddd, J = 5.0, 9.0, 9.0 Hz, 1H), 5.57 (ddd, J = 2.5, 2.5, 5.0 Hz, 1H), 7.16–7.33 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 3.7, 23.5, 23.9, 29.4, 29.7, 53.4, 56.3, 57.8, 66.6, 76.8, 78.7, 126.4, 127.3, 127.5, 128.3, 128.8, 128.9, 129.2, 130.6, 140.3, 141.2, 157.5, 209.5; IR (thin film) cm−1 3403brs, 3061w, 3029w, 2921w, 1751s, 1711m, 1674w, 1600w, 1494w, 1477w, 1452w, 1408m; HRMS (QTOF MS ESI) m/e calcd for C27H28NO3 [M + H]+ 414.2064, found 414.2063.9e was obtained (17 mg, 61%) on a 24.0 mg scale reaction as a yellow solid according to the general procedure, mp 82–83 °C; Rf = 0.35 (hexane: EtOAc = 1:1); [α]D25 = 50.8 (c = 0.87, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.92–1.00 (m, 1H0, 1.74–1.79 (m, 1H0, 1.831.88 (m, 1H), 2.11–2.19 (m, 1H), 2.24 (s, 3H), 2.85 (ddd, J = 3.0, 9.0, 12.0 Hz, 1H), 3.49–3.51 (m, 1H), 4.05 (dd, J = 5.0, 9.0 Hz, 1H0, 4.25 (d, J = 9.0 Hz, 1H), 4.38 (dd, J = 9.0, 9.0 Hz, 1H), 4.94 (ddd, J = 5.0, 9.0, 9.0 Hz, 1H), 5.63 (ddd, J = 2.5, 5.0, 5.0 Hz, 1H), 7.18–7.33 (m, 13H), 7.36–7.38 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 23.5, 23.9, 29.6, 30.5, 53.0, 56.6, 57.9, 66.7, 83.2, 87.1, 122.8, 127.1, 127.4, 127.5, 128.2, 128.4, 128.5, 128.8, 128.9, 129.2, 130.1, 131.8, 140.3, 141.3, 157.6, 209.2; IR (thin film) cm−1 3405brs, 3059w, 2923w, 1754s, 1713m, 1675w, 1599w, 1491w, 1452w, 1408m; HRMS (QTOF MS ESI) m/e calcd for C32H30NO3 [M + H]+ 476.2220, found 476.2220.9f was obtained (27 mg, 72%) on a 30.0 mg scale reaction as a yellow solid according to the general procedure, mp 82–83 °C; Rf = 0.40 (hexane:EtOAc = 2:1); [α]D25 = 6.9 (c = 0.71, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.94 (ddd, J = 5.5, 10.5, 10.5 Hz, 1H), 1.65 (d, J = 2.5 Hz, 3H), 1.68–1.70 (m, 1H), 1.78–1.84 (m, 1H), 2.14–2.22 (m, 1H), 3.39–3.41 (m, 1H), 3.56 (ddd, J = 2.5, 9.0, 12.0 Hz, 1H), 4.07 (dd, J = 4.5, 9.0 Hz, 1H), 4.23 (d, J = 9.5 Hz, 1H), 4.40 (dd, J = 9.0, 9.0 Hz, 1H), 4.91 (ddd, J = 4.5, 9.0, 9.0 Hz, 1H), 5.61 (ddd, J = 2.5, 2.5, 5.0 Hz, 1H), 7.17–7.20 (m, 1H), 7.23–7.35 (m, 9H), 7.62 (d, J = 8.5 Hz, 2H), 7.81 (d, J = 8.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 3.7, 24.1, 25.0, 30.6, 48.0, 56.8, 57.9, 66.9, 76.6, 79.2, 126.9, 127.4, 127.5, 128.3, 128.7, 128.8, 129.0, 129.3, 130.2, 130.9, 132.2, 135.0, 140.5, 141.3, 157.7, 200.5; IR (thin film) cm−1 3398brs, 2922w, 1752s, 1681m, 1585m, 1494w, 1452w, 1409m; HRMS (QTOF MS ESI) m/e calcd for C32H23BrNO3 [M + H]+ 554.1325, found 554.1329.
  • 16.Procedure of Pauson-Khand reaction: To a solution of E-5a (44 mg, 0.2 mmol) in toluene (4.0 mL) was added Co2(CO)8 (82 mg, 0.24 mmol) under Ar. The mixture was stirred at rt until the starting material was completely consumed as indicated by TLC (ca 3 h), then norbornene (56.5 mg, 0.6 mmol) and NMO (117 mg, 1.0 equiv) were added successively and the mixture was further stirred at 110 °C overnight. The reaction mixture was concentrated under reduced pressure to afford a crude mixture which was further purified via silica gel flash column chromatography [gradient eluent: EtOAc in hexane] to afford product 11 (19 mg, 28%) as a pale yellow oil. Rf = 0.40 (hexane:EtOAc = 2:1); 1H NMR (500 MHz, CDCl3) δ 0.89 (d, J = 7.0 Hz, 3H), 0.96 (d, J = 7.0 Hz, 3H), 1.00–1.01 (m, 1H), 1.02 (m, 1H), 1.25–1.36 (m, 2H), 1.57–1.64 (m, 1H0, 1.67–1.74 (m, 1H), 1.99–2.07 (m, 1H), 2.05 (s, 3H), 2.24 (d, J = 5.5 Hz, 1H), 2.33 (dd, J = 4.0, 15.0 Hz, 1H), 2.44 (dd, J = 5.0, 5.0 Hz, 1H), 2.57 (d, J = 5.0 Hz, 1H), 4.04 (dddd, J = 2.0, 4.0, 5.5, 5.5 Hz, 1H), 4.19 (dd, J= 5.5, 8.5 Hz, 1H), 4.36 (dd, J = 9.0, 9.0 Hz, 1H), 5.28–5.34 (m, 2H), 6.05 (ddd, J = 6.0, 17.5, 19.5 Hz, 1H), 6.12 (d, J = 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.8/14.9, 18.1, 18.2, 28.7, 28.9, 29.3, 31.8, 38.0, 39.2, 53.5/53.8, 54.2/54.3, 60.9/61.0, 63.5/63.5, 117.2/117.3, 122.2, 129.9/130.0, 135.4, 138.8/138.9, 157.3, 175.7, 208.2/208.5; HRMS (QTOF MS ESI) m/e calcd for C23H28NO3 [M + H]+ 359.2330, found 359.2334.
  • 17.ORCID number of Z.-X. Ma: 0000-0002-9971-5158

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp Info

RESOURCES